Works matching AU Tempero, Margaret

Results: 31

CLOSING THOUGHTS.

Published in:

Oncology (08909091), 2007, v. 21, n. 11, p. 1408

By:

Zerhouni, Elias A.;
Niederhuber, John E.;
Raghavan, Derek;
Ettinger, David S.;
Rosen, Steve;
Tempero, Margaret;
Varmus, Harold;
Davidson, Nancy;
Vogelstein, Bert

Publication type:

Article

Effects of sodium cholate on experimental carcinogenesis and cell proliferation in an excluded colonic segment.

Published in:

Journal of Surgical Oncology, 1987, v. 36, n. 4, p. 253, doi. 10.1002/jso.2930360408

By:

Tempero, Margaret A.;
Zetterman, Rowen K.

Publication type:

Article

Hexamethylmelamine and melphalan as salvage therapy in advanced ovarian carcinoma.

Published in:

Journal of Surgical Oncology, 1982, v. 21, n. 3, p. 159, doi. 10.1002/jso.2930210305

By:

Tempero, Margaret A.;
Kessinger, Anne

Publication type:

Article

Bile Acids, Ornithine Decarboxylase, and Cell Proliferation in Colon Cancer: A Review.

Published in:

Digestive Diseases, 1986, v. 4, n. 1, p. 49, doi. 10.1159/000171137

By:

Tempero, Margaret

Publication type:

Article

Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-pan-2 in normal, benign and malignant pancreatic tissue.

Published in:

International Journal of Cancer, 1988, v. 42, n. 5, p. 681, doi. 10.1002/ijc.2910420508

By:

Takasaki, Hideaki;
Tempero, Margaret A.;
Uchida, Eiji;
Büchler, Markus;
Ness, Marsha J.;
Burnett, David A.;
Metzgar, Richard S.;
Colcher, David;
Schlom, Jeffrey;
Pour, Parviz M.

Publication type:

Article

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

Published in:

Nature Medicine, 2011, v. 17, n. 4, p. 500, doi. 10.1038/nm.2344

By:

Collisson, Eric A.;
Sadanandam, Anguraj;
Olson, Peter;
Gibb, William J.;
Truitt, Morgan;
Gu, Shenda;
Cooc, Janine;
Weinkle, Jennifer;
Kim, Grace E.;
Jakkula, Lakshmi;
Feiler, Heidi S.;
Ko, Andrew H.;
Olshen, Adam B.;
Danenberg, Kathleen L.;
Tempero, Margaret A.;
Spellman, Paul T.;
Hanahan, Douglas;
Gray, Joe W.

Publication type:

Article

Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.

Published in:

2017

By:

Capello, Michela;
Bantis, Leonidas E.;
Scelo, Ghislaine;
Yang Zhao;
Peng Li;
Dhillon, Dilsher S.;
Patel, Nikul J.;
Kundnani, Deepali L.;
Hong Wang;
Abbruzzese, James L.;
Maitra, Anirban;
Tempero, Margaret A.;
Brand, Randall;
Firpo, Matthew A.;
Mulvihill, Sean J.;
Katz, Matthew H.;
Brennan, Paul;
Ziding Feng;
Ayumu Taguchi;
Hanash, Samir M.

Publication type:

journal article

A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 6, p. 875, doi. 10.1007/s00280-012-1979-7

By:

Ko, Andrew;
Truong, Thach-Giao;
Kantoff, Emily;
Jones, Kimberly;
Dito, Elizabeth;
Ong, Anna;
Tempero, Margaret

Publication type:

Article

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1051, doi. 10.1007/s00280-010-1257-5

By:

Ko, Andrew H.;
Venook, Alan P.;
Bergsland, Emily K.;
Kelley, R. Kate;
Korn, W. Michael;
Dito, Elizabeth;
Schillinger, Brian;
Scott, Janet;
Hwang, Jimmy;
Tempero, Margaret A.

Publication type:

Article

ASO Visual Abstract: Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.

Published in:

2024

By:

Miller, Phoebe N.;
Romero-Hernandez, Fernanda;
Calthorpe, Lucia;
Wang, Jaeyun Jane;
Kim, Sunhee S.;
Corvera, Carlos U.;
Hirose, Kenzo;
Kirkwood, Kimberly S.;
Hirose, Ryutaro;
Maker, Ajay V.;
Alseidi, Adnan A.;
Adam, Mohamed A.;
Kim, Grace E.;
Tempero, Margaret A.;
Ko, Andrew H.;
Nakakura, Eric K.

Publication type:

Abstract

Long-Duration Neoadjuvant Therapy with FOLFIRINOX Yields Favorable Outcomes for Patients Who Undergo Surgery for Pancreatic Cancer.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 9, p. 6147, doi. 10.1245/s10434-024-15579-0

By:

Miller, Phoebe N.;
Romero-Hernandez, Fernanda;
Calthorpe, Lucia;
Wang, Jaeyun Jane;
Kim, Sunhee S.;
Corvera, Carlos U.;
Hirose, Kenzo;
Kirkwood, Kimberly S.;
Hirose, Ryutaro;
Maker, Ajay V.;
Alseidi, Adnan A.;
Adam, Mohamed A.;
Kim, Grace E.;
Tempero, Margaret A.;
Ko, Andrew H.;
Nakakura, Eric K.

Publication type:

Article

Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.

Published in:

Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7545, doi. 10.1245/s10434-021-09816-z

By:

Reni, Michele;
Braverman, Julia;
Hendifar, Andrew;
Li, Chung-Pin;
Macarulla, Teresa;
Oh, Do-Youn;
Riess, Hanno;
Tempero, Margaret;
Lu, Brian;
Marcus, James;
Joshi, Namita;
Botteman, Marc;
Dueck, Amylou C.

Publication type:

Article

Thrombocytopenia and laboratory evidence of disseminated intravascular coagulation after shunts for ascites in malignant disease.

Published in:

1985

By:

Tempero, Margaret A.;
Davis, Richard B.;
Reed, Elizabeth;
Edney, James;
Tempero, M A;
Davis, R B;
Reed, E;
Edney, J

Publication type:

journal article

Excess Toxicity Associated with Docetaxel and Irinotecan in Patients with Metastatic, Gemcitabine-Refractory Pancreatic Cancer: Results of a Phase II Study.

Published in:

Cancer Investigation, 2008, v. 26, n. 1, p. 47, doi. 10.1080/07357900701681483

By:

Ko, Andrew H.;
Dito, Elizabeth;
Schillinger, Brian;
Venook, Alan P.;
Bergsland, Emily K.;
Tempero, Margaret A.

Publication type:

Article

Implementation of an Embedded In‐Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma.

Published in:

Oncologist, 2021, v. 26, n. 11, p. e1982, doi. 10.1002/onco.13968

By:

Walker, Evan J.;
Goldberg, Dena;
Gordon, Kelly M.;
Pedley, Christina;
Carnevale, Julia;
Cinar, Pelin;
Collisson, Eric A.;
Tempero, Margaret A.;
Ko, Andrew H.;
Blanco, Amie M.;
Dhawan, Mallika

Publication type:

Article

A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.

Published in:

Oncologist, 2017, v. 22, n. 12, p. 1427, doi. 10.1634/theoncologist.2017-0066

By:

Ko, Andrew H.;
Murphy, Patrick B.;
Peyton, James D.;
Shipley, Dianna L.;
Al‐Hazzouri, Ahmed;
Rodriguez, Francisco A.;
Womack, Mark S.;
Xiong, Henry Q.;
Waterhouse, David M.;
Tempero, Margaret A.;
Guo, Shuangli;
Lane, Cassie M.;
Earwood, Chris;
DeBusk, Laura M.;
Bendell, Johanna C.

Publication type:

Article

Fatal pulmonary toxicity resulting from treatment with gemcitabine.

Published in:

1998

By:

Tempero, Margaret A.;
Brand, Randall;
Tempero, M A;
Brand, R

Publication type:

Case Study

Pitfalls in antibody imaging in colorectal cancer.

Published in:

Cancer (0008543X), 1993, v. 71, n. S12, p. 4248, doi. 10.1002/1097-0142(19930615)71:12+<4248::AID-CNCR2820711814>3.0.CO;2-T

By:

Tempero, Margaret

Publication type:

Article

Potentiation of Radioimmunotherapy with Response-Selective Peptide Agonist of Human C5a.

Published in:

Journal of Nuclear Medicine, 2002, v. 43, n. 7, p. 957

By:

Kurizaki, Takashi;
Okazaki, Shinji;
Sanderson, Sam D.;
Colcher, David;
Enke, Charles A.;
Tempero, Margaret A.;
Baranowska-Kortylewicz, Janina

Publication type:

Article

Outpatient Treatment with <sup>131</sup>I-Anti-B1 Antibody: Radiation Exposure to Family Members.

Published in:

Journal of Nuclear Medicine, 2001, v. 42, n. 6, p. 907

By:

Rutar, Frank J.;
Augustine, Samuel C.;
Colcher, David;
Siegel, Jeffry A.;
Jacobson, David A.;
Tempero, Margaret A.;
Dukat, Valorie J.;
Hohenstein, Maribeth A.;
Gobar, Lisa S.;
Vose, Julie M.

Publication type:

Article

Patient-Specific Dosimetry of Indium-111- and Yttrium-90-Labeled Monoclonal Antibody CC49.

Published in:

Journal of Nuclear Medicine, 1997, v. 38, n. 4, p. 512

By:

Leichner, Peter K.;
Akabani, Gamal;
Colcher, David;
Harrison, Katherine A.;
Hawkins, William G.;
Eckblade, Miriam;
Baranowska-Kortylewicz, Janina;
Augustine, Samuel C.;
Wisecarver, James;
Tempero, Margaret A.

Publication type:

Article

HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.

Published in:

NMR in Biomedicine, 2014, v. 27, n. 11, p. 1361, doi. 10.1002/nbm.3198

By:

Wang, Alan S.;
Lodi, Alessia;
Rivera, Lee B.;
Izquierdo‐Garcia, Jose L.;
Firpo, Matthew A.;
Mulvihill, Sean J.;
Tempero, Margaret A.;
Bergers, Gabriele;
Ronen, Sabrina M.

Publication type:

Article

Walking a Difficult Path Is Easier with a Friend.

Published in:

Annals of the New York Academy of Sciences, 1997, v. 809, n. 1, p. 237, doi. 10.1111/j.1749-6632.1997.tb48086.x

By:

TEMPERO, MARGARET A.

Publication type:

Article

Cancer Therapy Using Radioimmunoconjugates.

Published in:

Annals of the New York Academy of Sciences, 1993, v. 698, n. 1, p. 406, doi. 10.1111/j.1749-6632.1993.tb17234.x

By:

TEMPERO, MARGARET;
COLCHER, DAVID;
DALRYMPLE, GLENN;
HARRISON, KATHERINE;
HOLDEMAN, KAREN;
JOSHI, SHANTARAM;
QUADRI, SYED;
LINDER, JAMES;
AUGUSTINE, SAM;
REED, ELIZABETH;
LEICHNER, PETER

Publication type:

Article

Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.

Published in:

Familial Cancer, 2019, v. 18, n. 2, p. 241, doi. 10.1007/s10689-018-0106-2

By:

Walker, Evan J.;
Carnevale, Julia;
Pedley, Christina;
Blanco, Amie;
Chan, Salina;
Collisson, Eric A.;
Tempero, Margaret A.;
Ko, Andrew H.

Publication type:

Article

Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?

Published in:

Journal of Surgical Oncology, 2016, v. 114, n. 5, p. 587, doi. 10.1002/jso.24375

By:

Kim, Sunhee S.;
Nakakura, Eric K.;
Wang, Zhen J.;
Kim, Grace E.;
Corvera, Carlos U.;
Harris, Hobart W.;
Kirkwood, Kimberly S.;
Hirose, Ryutaro;
Tempero, Margaret A.;
Ko, Andrew H.

Publication type:

Article

A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?

Published in:

Investigational New Drugs, 2008, v. 26, n. 5, p. 463, doi. 10.1007/s10637-008-9127-2

By:

Andrew Ko;
Elizabeth Dito;
Brian Schillinger;
Alan Venook;
Zhidong Xu;
Emily Bergsland;
Derrick Wong;
Janet Scott;
Jimmy Hwang;
Margaret Tempero

Publication type:

Article

Phase II trial of nolatrexed dihydrochloride [Thymitaq<sup>TM</sup>, AG 337] in patients with advanced hepatocellular carcinoma.

Published in:

Investigational New Drugs, 2007, v. 25, n. 1, p. 85, doi. 10.1007/s10637-006-9003-x

By:

Minaxi Jhawer;
Lee Rosen;
Janet Dancey;
Howard Hochster;
Solomon Hamburg;
Margaret Tempero;
Neil Clendeninn;
Sridhar Mani

Publication type:

Article

Germline Testing, Molecular Profiling Now Recommended in NCCN Pancreatic Cancer Guideline.

Published in:

Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 5, p. 195

By:

Tempero, Margaret A.

Publication type:

Article

Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil.

Published in:

Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 3, p. 247, doi. 10.1007/s002800050036

By:

Gwilt, Peter;
Tempero, Margaret;
Kremer, Alton;
Connolly, Mary;
Ding, Cliff

Publication type:

Article

Current and future strategies for combined-modality therapy in pancreatic cancer.

Published in:

Current Oncology Reports, 2002, v. 4, n. 3, p. 202, doi. 10.1007/s11912-002-0017-z

By:

Ko, Andrew;
Tempero, Margaret

Publication type:

Article